NCT02310763 A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE2
NCT02295748 An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort Status COMPLETED Phase PHASE1
NCT02285673 Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy Status UNKNOWN Phase PHASE1/PHASE2
NCT02251600 A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE1
NCT02196467 Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT02168114 Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle Status COMPLETED Phase NA
NCT02167217 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE2
NCT02056808 A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE1
NCT02034305 Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy Status COMPLETED Phase N/A
NCT01963897 Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life. Status COMPLETED Phase N/A
NCT01957059 A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD) Status TERMINATED Phase PHASE1/PHASE2
NCT01954940 Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy Status COMPLETED Phase NA